secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060293
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences Q3 revenue up 7% to $20.0M, withdraws FY 2023 guidance on LCD uncertainty
--------------------------------------------------------------------------------

- Q3 revenue $20.0M (+7% YoY); Surgical Glaucoma $18.4M (+8% YoY); Dry Eye $1.6M (-1% YoY).
- Net loss $13.0M ($0.27 per share) vs $22.2M ($0.46) a year ago; gross margin 86.6% (vs 84.3%).
- Withdraws full-year 2023 revenue and adjusted operating expense guidance due to WPS LCD uncertainty.
- Implements ~10% RIF expecting $7.9M annualized savings; other cost initiatives ~$5.0M annual savings.
- Appointed Matt Link as Chief Commercial Officer; GEMINI 2 study shows sustained IOP reduction at 36 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000095017023060293/0000950170-23-060293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000095017023060293/sght-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer